Skip to main content

Call-to-Action
for Improved Education, Awareness and Support
for Head and Neck Cancer Patients

In order to reduce the senseless number of lives lost to head and neck cancer each year, we call on healthcare professionals across Europe to facilitate earlier diagnosis and patient care by committing to:

  • Improving education and knowledge-sharing among healthcare professionals
  • Raising awareness of the signs and symptoms of head and neck cancer to prevent patients presenting at late stage when more radical treatment is necessary, and prognosis is less favourable (Donell A, et al, The Journal of Stomatological Investigation 2008;2;15-26.)
  • Providing additional support for patients to ensure they are receiving the right level of information, so that they are better informed and more able to deal with the emotional and psychological aspects of the disease.
prof lefebvre at the call-to-action1

Call-to-Action for Healthcare Professionals to
Improve Education and Support for Patients with Head and Neck Cancer

Stockholm, Sweden, September 26, 2011 – The European Head and Neck Society (EHNS), together with a group of leading global experts, will today issue a call for healthcare professionals to improve education, awareness and support for head and neck cancer patients. The call will be issued during the Senseless Satellite Symposium at the 2011 European Multidisciplinary Cancer Congress. The symposium is being hosted by the EHNS in partnership with Merck Serono, a division of Merck KGaA, Darmstadt Germany.

The call-to-action was inspired by results of ‘About Face 2’, a new survey of European head and neck cancer patients, which found unmet needs at key points of the patient pathway. Leading experts, including Professor Jean-Louis Lefebvre, lead author of the ‘About Face 2’ survey abstract and President of the EHNS, will call on physicians to help reduce the number of lives lost to head and neck cancer through earlier diagnosis and patient care by:

  • Improving education and knowledge-sharing among healthcare professionals
  • Raising awareness of the signs and symptoms of head and neck cancer to prevent patients presenting at late stage when more radical treatment is necessary, and prognosis is less favourable (Donell A, et al, The Journal of Stomatological Investigation 2008;2;15-26.)
  • Providing additional support for patients to ensure they are receiving the right level of information, so that they are better informed and more able to deal with the emotional and psychological aspects of the disease

The EHNS is taking an important step towards improving education and support for patients with head and neck cancer. We hope our call-to-action will encourage other healthcare professionals to tackle the unmet needs expressed by patients in this difficult-to-treat area

said Professor Lefebvre.

Following the announcement of the call-to-action, the EHNS will continue working with the expert panel to inspire positive change through a carefully considered action plan, campaigning for better awareness, education and support for head and neck cancer patients.

"About Face 2" Survey
(Data: 2011)

Introduction

  • The ‘About Face 2’ survey investigated issues identified by the earlier ‘About Face’ survey
  • These issues included the experiences, needs and quality of life (QoL) of patients with head and neck cancer

quote05

Methodology

  • Interview-based pan-European survey of 104 head and neck cancer patients from Belgium, France, Portugal, Italy, Spain and Sweden
  • Questions were based on recall of patients’ own experiences in terms of:
    • Pre-diagnosis
    • At diagnosis
    • At treatment
    • Post-treatment
    • Impact of the disease, including quality of life and side effects

quote06a

Key findings

  • At every stage of the journey, patients want better communication and understanding
  • The overwhelming majority of patients were not aware of head and neck cancer before diagnosis
  • Many said physicians did not take early symptoms seriously
  • Information about treatment has to be tailored to the individual

The results from the ‘About Face 2’ survey were presented by Professor Jean-Louis Lefebvre as a poster session at the 2011 European Multidisciplinary Cancer Congress (EMCC).

They just said I was going to have treatment but they didn’t explain the treatment, the side effects or the consequences – how long it would last and how long it would be before I could work again – they didn’t tell me anything

(Patient, France)

I was put on a chemotherapy protocol and I saw the oncologist every 2 weeks but I wasn’t given any explanation about it, I was just hooked up to it and I didn’t know anything about the doses

(Patient, Italy)